Inventor · disambiguated record
Mark D. Erion
Also filed as: ERION MARK · ERION MARK D · ERION MARK DAVID
61 granted patents·18 pending applications·2,998 citations·filing 1989–2024
99Inventor score
Top patents by PatentIndex Score
79 records- 0198US6489476B1Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1999·Granted Dec 3, 2002·231 cites·165 claims
- 0298US6312662B1Prodrugs phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 1999·Granted Nov 6, 2001·384 cites·183 claims
- 0397US6752981B1Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 22, 2004·105 cites·92 claims
- 0497US6399782B1Benzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 4, 2002·136 cites·37 claims
- 0596US6110903ABenzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Aug 29, 2000·132 cites·52 claims
- 0696US6054587AIndole and azaindole inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Apr 25, 2000·147 cites·47 claims
- 0796US5294632APhosphono/biaryl substituted dipetide derivativesCIBA GEIGY CORP·Filed 1992·Granted Mar 15, 1994·175 cites·10 claims
- 0895US6946115B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Sep 20, 2005·51 cites·18 claims
- 0995US6294672B1Indole and azaindole inhibitors of Fructose-1,6-biphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Sep 25, 2001·52 cites·22 claims
- 1095US6284748B1Purine inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Sep 4, 2001·137 cites·39 claims
- 1195US5155100APhosphono/biaryl substituted dipeptide derivativesCIBA GEIGY CORP·Filed 1991·Granted Oct 13, 1992·159 cites·21 claims
- 1294US7514419B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 7, 2009·25 cites·18 claims
- 1393US5506347ALyxofuranosyl analogues of adenosineGENSIA INC·Filed 1994·Granted Apr 9, 1996·133 cites·51 claims
- 1492US5674998AC-4' modified adenosine kinase inhibitorsGENSIA INC·Filed 1995·Granted Oct 7, 1997·109 cites·44 claims
- 1592US5008270A2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the sameBIOCRYST INC·Filed 1989·Granted Apr 16, 1991·33 cites·19 claims
- 1691US7351399B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 1, 2008·8 cites·9 claims
- 1791US5646128AMethods for treating adenosine kinase related conditionsGENSIA INC·Filed 1994·Granted Jul 8, 1997·137 cites·13 claims
- 1891US4985434A7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the sameBIOCRYST INC·Filed 1989·Granted Jan 15, 1991·31 cites·14 claims
- 1990US7553826B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·11 cites·29 claims
- 2089US11951114B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·1 cites·6 claims
- 2189US7666855B22′-C-methyl nucleoside derivativesMETABASIS THERAPEUTICS INC·Filed 2006·Granted Feb 23, 2010·12 cites·37 claims
- 2289US5763597AOrally active adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·125 cites·28 claims
- 2389US5763596AC-4' modified adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·117 cites·32 claims
- 2489US5008265A2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the sameBIOCRYST INC·Filed 1989·Granted Apr 16, 1991·27 cites·13 claims
- 2588US7816345B2Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2007·Granted Oct 19, 2010·8 cites·55 claims
- 2688US6967193B1Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Nov 22, 2005·27 cites·6 claims
- 2788US4985433A2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the sameBIOCRYST INC·Filed 1989·Granted Jan 15, 1991·25 cites·9 claims
- 2887US7829552B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2004·Granted Nov 9, 2010·24 cites·16 claims
- 2987US5795977AWater soluble adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Aug 18, 1998·106 cites·21 claims
- 3086US11351183B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2017·Granted Jun 7, 2022·6 cites·20 claims
- 3186US8962618B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofREDDY K RAJA·Filed 2012·Granted Feb 24, 2015·7 cites·6 claims
- 3285US10130643B2Thyromimetics for the treatment of fatty liver diseasesCABLE EDWARD E·Filed 2010·Granted Nov 20, 2018·15 cites·27 claims
- 3385US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 3485US7205404B1Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Apr 17, 2007·17 cites·61 claims
- 3585US7151092B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 19, 2006·13 cites·11 claims
- 3684US10925885B2Thyromimetics for the treatment of fatty liver diseasesMETABASIS THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·4 cites·25 claims
- 3784US9809545B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·4 cites·7 claims
- 3884US8080536B2Phosphorus-containing prodrugsERION MARK D·Filed 2010·Granted Dec 20, 2011·6 cites·26 claims
- 3983US8664195B2Phosphorus-containing prodrugsERION MARK D·Filed 2011·Granted Mar 4, 2014·5 cites·78 claims
- 4082US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 4182US7303739B2Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·14 cites·88 claims
- 4282US6756360B1Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetesMETABASIS THERAPEUTICS INC·Filed 1999·Granted Jun 29, 2004·48 cites·74 claims
- 4381US5189039A7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the sameBIOCRYST INC·Filed 1991·Granted Feb 23, 1993·22 cites·26 claims
- 4479US8940927B2Activators of glucokinaseTIAN FENG·Filed 2011·Granted Jan 27, 2015·4 cites·31 claims
- 4579US7312219B2Heteroaromatic inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 25, 2007·10 cites·145 claims
- 4679US7214668B2Phosphonic acid based prodrugs of PMEA and its analoguesMETABASIS THERAPEUTICS INC·Filed 2003·Granted May 8, 2007·16 cites·30 claims
- 4778US12440502B2Use of thyroid beta-agonistsVIKING THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·7 claims
- 4877US7285543B2Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2005·Granted Oct 23, 2007·2 cites·6 claims
- 4976US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 5074US5775329AMethod and compounds for diagnosing coronary artery diseaseGENSIA INC·Filed 1995·Granted Jul 7, 1998·15 cites·20 claims
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mark D. Erion files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →